CAP ARRIELLO LIMITED

Cap Arriello Limited is a leading provider of end-to-end regulatory, pharmacovigilance, quality and compliance solutions for innovative life-sciences companies. Drawing on deep scientific expertise, the firm guides clients through every stage of product development - from clinical-trial authorisation and safety data management to marketing-authorisation submissions and post-launch lifecycle support - helping to accelerate time-to-market while safeguarding patient safety.

The company's service portfolio spans clinical safety, EU-QPPV and local PV officer provision, safety-data management, signal detection, medical writing and pharmacovigilance IT systems. In regulatory affairs it offers intelligence, strategy, dossier development, scientific advice, paediatric investigation plans, orphan-drug designation and full-scale applications and submissions across EU, US, LATAM, MENA, CIS, APAC and South Africa. Its quality and compliance arm delivers GxP auditing, inspection readiness, technical consulting, quality-risk management, QMS/PQS implementation and responsible-person services, as well as commercialisation-readiness and supply-chain mapping.

With a network of over 128 audited partners operating in more than 150 countries, Cap Arriello provides a scalable, client-centric platform that blends strategic consultancy with operational capability, ensuring that products launch safely, remain compliant and achieve market success.